Cargando…

Personalising Alzheimer’s Disease progression using brain atrophy markers

INTRODUCTION: Neuroanatomical normative modelling can capture individual variability in Alzheimer’s Disease (AD). We used neuroanatomical normative modelling to track individuals’ disease progression in people with mild cognitive impairment (MCI) and patients with AD. METHODS: Cortical thickness and...

Descripción completa

Detalles Bibliográficos
Autores principales: Verdi, Serena, Rutherford, Saige, Fraza, Charlotte, Tosun, Duygu, Altmann, Andre, Raket, Lars Lau, Schott, Jonathan M., Marquand, Andre F., Cole, James H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312850/
https://www.ncbi.nlm.nih.gov/pubmed/37398392
http://dx.doi.org/10.1101/2023.06.15.23291418
_version_ 1785066998821027840
author Verdi, Serena
Rutherford, Saige
Fraza, Charlotte
Tosun, Duygu
Altmann, Andre
Raket, Lars Lau
Schott, Jonathan M.
Marquand, Andre F.
Cole, James H.
author_facet Verdi, Serena
Rutherford, Saige
Fraza, Charlotte
Tosun, Duygu
Altmann, Andre
Raket, Lars Lau
Schott, Jonathan M.
Marquand, Andre F.
Cole, James H.
author_sort Verdi, Serena
collection PubMed
description INTRODUCTION: Neuroanatomical normative modelling can capture individual variability in Alzheimer’s Disease (AD). We used neuroanatomical normative modelling to track individuals’ disease progression in people with mild cognitive impairment (MCI) and patients with AD. METHODS: Cortical thickness and subcortical volume neuroanatomical normative models were generated using healthy controls (n~58k). These models were used to calculate regional Z-scores in 4361 T1-weighted MRI time-series scans. Regions with Z-scores <−1.96 were classified as outliers and mapped on the brain, and also summarised by total outlier count (tOC). RESULTS: Rate of change in tOC increased in AD and in people with MCI who converted to AD and correlated with multiple non-imaging markers. Moreover, a higher annual rate of change in tOC increased the risk of MCI progression to AD. Brain Z-score maps showed that the hippocampus had the highest rate of atrophy change. CONCLUSIONS: Individual-level atrophy rates can be tracked by using regional outlier maps and tOC.
format Online
Article
Text
id pubmed-10312850
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory
record_format MEDLINE/PubMed
spelling pubmed-103128502023-07-01 Personalising Alzheimer’s Disease progression using brain atrophy markers Verdi, Serena Rutherford, Saige Fraza, Charlotte Tosun, Duygu Altmann, Andre Raket, Lars Lau Schott, Jonathan M. Marquand, Andre F. Cole, James H. medRxiv Article INTRODUCTION: Neuroanatomical normative modelling can capture individual variability in Alzheimer’s Disease (AD). We used neuroanatomical normative modelling to track individuals’ disease progression in people with mild cognitive impairment (MCI) and patients with AD. METHODS: Cortical thickness and subcortical volume neuroanatomical normative models were generated using healthy controls (n~58k). These models were used to calculate regional Z-scores in 4361 T1-weighted MRI time-series scans. Regions with Z-scores <−1.96 were classified as outliers and mapped on the brain, and also summarised by total outlier count (tOC). RESULTS: Rate of change in tOC increased in AD and in people with MCI who converted to AD and correlated with multiple non-imaging markers. Moreover, a higher annual rate of change in tOC increased the risk of MCI progression to AD. Brain Z-score maps showed that the hippocampus had the highest rate of atrophy change. CONCLUSIONS: Individual-level atrophy rates can be tracked by using regional outlier maps and tOC. Cold Spring Harbor Laboratory 2023-06-16 /pmc/articles/PMC10312850/ /pubmed/37398392 http://dx.doi.org/10.1101/2023.06.15.23291418 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.
spellingShingle Article
Verdi, Serena
Rutherford, Saige
Fraza, Charlotte
Tosun, Duygu
Altmann, Andre
Raket, Lars Lau
Schott, Jonathan M.
Marquand, Andre F.
Cole, James H.
Personalising Alzheimer’s Disease progression using brain atrophy markers
title Personalising Alzheimer’s Disease progression using brain atrophy markers
title_full Personalising Alzheimer’s Disease progression using brain atrophy markers
title_fullStr Personalising Alzheimer’s Disease progression using brain atrophy markers
title_full_unstemmed Personalising Alzheimer’s Disease progression using brain atrophy markers
title_short Personalising Alzheimer’s Disease progression using brain atrophy markers
title_sort personalising alzheimer’s disease progression using brain atrophy markers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312850/
https://www.ncbi.nlm.nih.gov/pubmed/37398392
http://dx.doi.org/10.1101/2023.06.15.23291418
work_keys_str_mv AT verdiserena personalisingalzheimersdiseaseprogressionusingbrainatrophymarkers
AT rutherfordsaige personalisingalzheimersdiseaseprogressionusingbrainatrophymarkers
AT frazacharlotte personalisingalzheimersdiseaseprogressionusingbrainatrophymarkers
AT tosunduygu personalisingalzheimersdiseaseprogressionusingbrainatrophymarkers
AT altmannandre personalisingalzheimersdiseaseprogressionusingbrainatrophymarkers
AT raketlarslau personalisingalzheimersdiseaseprogressionusingbrainatrophymarkers
AT schottjonathanm personalisingalzheimersdiseaseprogressionusingbrainatrophymarkers
AT marquandandref personalisingalzheimersdiseaseprogressionusingbrainatrophymarkers
AT colejamesh personalisingalzheimersdiseaseprogressionusingbrainatrophymarkers
AT personalisingalzheimersdiseaseprogressionusingbrainatrophymarkers